Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H9N3O10 |
Molecular Weight | 271.1391 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O
InChI
InChIKey=BRBAEHHXGZRCBK-UHFFFAOYSA-N
InChI=1S/C5H9N3O10/c9-1-5(2-16-6(10)11,3-17-7(12)13)4-18-8(14)15/h9H,1-4H2
Pentrinitrol is a metabolite of pentaerythritol tetranitrate. It has been introduced as an antianginal agent for man. Pentrinitrol decrease myocardial oxygen consumption and have a relatively long duration of action. The pharmacologic effects of pentrinitrol are similar to those of nitroglycerin. However, the duration of action of pentrinitrol is longer. Pentrinitrol produced lower pre-exercise systolic blood pressures and systolic blood pressures at point of angina. Pentrinitrol should permit patients to have fewer episodes of angina pectoris resulting from minor increases in physical activity. The same protection may also exist against angina pectoris produced by psychic stress. However, patients should still be cautioned against physical activity or psychic stress that ordinarily provokes angina pectoris.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/357455
Single dose - 10 mg
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082519
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
C91005
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
1607-17-6
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL466660
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
4SL9HWA66P
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
DTXSID10862712
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
15353
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
SUB09707MIG
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
216-529-7
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
m8521
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
3363
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
C100210
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY | |||
|
3427
Created by
admin on Fri Dec 15 15:05:21 GMT 2023 , Edited by admin on Fri Dec 15 15:05:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY